Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Characterisation of anticytoplasmic antibodies and their clinical associations

Article Abstract:

Cytoplasmic immunofluorescent staining patterns for antibodies to cellular components in patients with rheumatoid diseases may signify immune reaction to proteins of the cell's nucleus. The antinuclear antibody (ANA) test for antibodies to proteins in the cell's nucleus is one diagnostic test given to patients with autoimmune diseases. Blood serum samples from 1173 patients with such diseases as systemic lupus erythematosus, rheumatoid arthritis, or scleroderma were incubated with cultured human skin cells. The skin cells were then stained to reveal the presence of antibodies to cellular components and viewed under the microscope. Overall, 6.4% of patients displayed staining patterns in the cytoplasm. Of samples from 33 patients with cytoplasmic staining who were ANA negative, a further assay of the exact antigen found that five were positive for antigens found in the nucleus but which may also be found in the cytoplasm.

Author: Koh, Wei-Howe, Dunphy, Juliet, Whyte, Jean, Dixey, Jonathan, McHugh, Neil John
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1995
Anticytoplasmic antibodies

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Rheumatoid factors: where are we now?

Article Abstract:

More research is needed to determine why rheumatoid factor (RF) can become involved in rheumatoid arthritis. RF is a naturally produced antibody against immunoglobulins, particularly IgG and IgM. This puts it in the class of antibodies called autoantibodies. Its normal function is to bind to antigen-antibody complexes and remove them. This is a beneficial action and yet RF appears to play a destructive role in rheumatoid arthritis and other autoimmune disorders.

Author: Axford, J.S., Soltys, A.J., Sutton, B.J.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1997
Rheumatoid factor

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27

Article Abstract:

The article presents an analysis of results found in a meta-search on spondylarthropathy, which is typically characterized as an autoimmune disease, a classification which the author calls into question. The issue is that the particulars of the interaction between human histocompatibiltiy antigen B27 (HLA-B27) and bacteria does not support the belief that it is an autoimmune disease.

Author: Ringrose, J.H.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1999
Statistical Data Included, Bacteria, HLA histocompatibility antigens, HLA antigens

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, Autoimmune diseases
Similar abstracts:
  • Abstracts: Prevention of infective endocarditis: guidelines from the American Heart Association. Assessing patients' caries risk
  • Abstracts: Comparisons of alcohol and other drug problems among Minnesota adolescents in 1989 and 1992. A clinic system to improve preschool vaccinations in a low socioeconomic status population
  • Abstracts: Mechanism of HIV persistence: implications for vaccines and therapy
  • Abstracts: HIV care: a capitated alternative. Long-term therapeutic strategies in HIV
  • Abstracts: Ulnar drift: or what not to teach students. Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy from chronic knee synovitis
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.